Related Experiment Video
Updated: Sep 18, 2025

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
Transcatheter valve-in-valve replacement for degenerated mitral bioprosthesis using Myval device
Serkan Aslan1, Ahmet Guner1, Hande Uysal1
1Department of Cardiology, University of Health Sciences, Istanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Türkiye.
None:
Structural valve deterioration in surgical bioprostheses may require redo valve surgery, which is associated with significant operative mortality and poor long-term survival. As an alternative treatment option, valve-in-valve (ViV) transcatheter mitral valve replacement (TMVR) has emerged for patients with symptomatic and severely degenerated bioprosthetic valves who are at high risk for redo cardiac surgery. This case report describes the first case of transseptal valve-in-valve-transcatheter mitral valve replacement in an 85-year-old female patient in Türkiye. The patient had a degenerated mitral bioprosthesis and was at high surgical risk. The patient had previously undergone valve-in-valve transcatheter aortic valve replacement. The procedure was completed successfully, and there were no complications during the postprocedural course.
Related Concept Videos
Mitral Stenosis III: Medical Management
Mitral Regurgitation III: Medical Management
Mitral Valve Prolapse I: Introduction
Mitral Valve Prolapse II: Assessment and Management
Mitral Regurgitation I: Introduction
Mitral Valve Prolapse III: Nursing Management

